Breaking News
Get 40% Off 0
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas tool Copy Portfolio
Close

908 Devices Inc (MASS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow 908 Devices's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6.85 -0.03    -0.44%
17/05 - Closed. Currency in USD ( Disclaimer )
After Hours
6.94
+0.09
+1.31%
18:53:18 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 139,393
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 6.70 - 6.93
908 Devices 6.85 -0.03 -0.44%

908 Devices Inc Company Profile

 
Get an in-depth profile of 908 Devices Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryHealthcare Equipment & Supplies
SectorHealthcare
Employees

230

Equity Type

ORD

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company’s products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Contact Information

Address 645 Summer Street
Boston, 02210
United States
Phone 857 254 1500
Fax -

Top Executives

Name Age Since Title
Kevin J. Knopp 48 2012 Co-Founder, CEO, President & Director
E. Kevin Hrusovsky 59 2013 Independent Chairman of the Board
Christopher D. Brown - 2021 Scientific Advisory Board Member
Mark D. Spoto 51 2012 Independent Director
Anne-Claude Gingras - 2021 Scientific Advisory Board Member
Rena Robinson - 2021 Scientific Advisory Board Member
Ileana Cristea - 2021 Scientific Advisory Board Member
Jesper V. Olsen - 2021 Scientific Advisory Board Member
Elena Chernokalskaya - 2021 Member of Scientific Advisory Board
John Erickson - 2021 Member of Scientific Advisory Board
Anthony J. Hunt 58 2022 Independent Director
Marcia T. Eisenberg 62 2021 Independent Director
John R. Yates - 2021 Scientific Advisory Board Member
Jennifer E. Van Eyk - 2021 Scientific Advisory Board Member
Michael J. Betenbaugh - 2021 Member of Scientific Advisory Board
Tim Charlebois - 2021 Member of Scientific Advisory Board
Krishnedndu Roy - 2021 Member of Scientific Advisory Board
Eugene Schaefer - 2021 Member of Scientific Advisory Board
Keith L. Crandell 63 2012 Independent Director
Joshua Coon - 2018 Member of Scientific Advisory Board
Fenel M. Eloi 64 2021 Independent Director
Jarrod Marto - 2018 Member of Scientific Advisory Board
Jeffrey P. George 49 2021 Independent Director
Jimmie Oxley - 2018 Member of Scientific Advisory Board
John Michael Ramsey 71 2012 Co-Chair of Scientific Advisory Board
Christopher David Brown 49 2012 Co-Founder, Chief Product Officer & Co-Chair of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MASS Comments

Write your thoughts about 908 Devices Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nick Gaponov
Nick Gaponov Dec 28, 2020 7:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lets see some good growth today!
Borbély Csaba
Borbély Csaba Dec 24, 2020 10:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ye i have huge profit
Nick Gaponov
Nick Gaponov Dec 24, 2020 9:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
you did it yey!!!
Nick Gaponov
Nick Gaponov Dec 24, 2020 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go Celtics lets go!
Nick Gaponov
Nick Gaponov Dec 24, 2020 9:38AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
c'mon give me $70 a share!
Nick Gaponov
Nick Gaponov Dec 24, 2020 9:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I like it! I like it!
Nick Gaponov
Nick Gaponov Dec 24, 2020 9:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
65.50 in the money!
Nick Gaponov
Nick Gaponov Dec 24, 2020 9:24AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lets see +15.00 today!!
Borbély Csaba
Borbély Csaba Dec 23, 2020 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
welcome: im in since 50 so lets go:)
Nick Gaponov
Nick Gaponov Dec 23, 2020 1:06PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
im in since 64.32. im hopefull lol
Nick Gaponov
Nick Gaponov Dec 23, 2020 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
welcome to stock market
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email